RecallHawk

VASOPRESSIN IN 0.9% SODIUM CHLORIDE (VASOPRESSIN)

LONG GROVE PHARMS

Summary

FDA approved VASOPRESSIN IN 0.9% SODIUM CHLORIDE (VASOPRESSIN) by LONG GROVE PHARMS. NDA (New Drug) approval (Type 3 - New Dosage Form) on 2024-07-11. SOLUTION, INTRAVENOUS.

Details

Source

Drug Approval

External ID

NDA217766-1

Action Date

2024-07-11

Status

Approved

Category

drug

Product Code

NDA (New Drug)

Product Description

VASOPRESSIN IN 0.9% SODIUM CHLORIDE (generic: VASOPRESSIN), SOLUTION, INTRAVENOUS. Application: NDA217766

Context & Analysis

LONG GROVE PHARMS has 6 FDA actions in our database.

Frequently Asked Questions

How often does LONG GROVE PHARMS have FDA actions?

LONG GROVE PHARMS has 6 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "NDA217766-1" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions